Work Here?
Overview
Cara Care builds a mobile app that delivers a personalized, multi-therapy program for digestive conditions like IBS, IBD, and GERD. The app combines nutritional therapy, care from certified psychologists, and a digital diary to track symptoms, diet, and well-being, guiding users through individualized plans that adapt over time. In Germany the program is a DiGA prescription medical device reimbursed by statutory health insurances, and the company also offers a US version, supported by investor funding and clinical studies validating its effectiveness. Its goal is to improve access to evidence-based digestive care and support long-term symptom management, while expanding internationally and continuing clinical validation.
About Cara Care
Industries
Consumer Software
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Early VC
Total Funding
$17.4M
Headquarters
Berlin, Germany
Founded
2016
Get referred to Cara Care
See people who can refer or advise you
Simplify's Take
What believers are saying
- In March 2026, Germany granted permanent reimbursement for Cara Care IBS.
- Mahana says Cara Care serves thousands of German patients and tens of thousands worldwide.
- Mahana's 2024 acquisition funds European expansion into France and the United Kingdom.
What critics are saying
- Mahana's 2022 layoffs cut roughly half the company, signaling chronic cost pressure.
- GKV-SV controls German reimbursement pricing; price cuts directly squeeze Cara Care margins.
- If Mahana deprioritizes digestion, Cara Care becomes an orphaned product inside a larger portfolio.
What makes Cara Care unique
- Cara Care is Mahana's digestive-health anchor, spanning IBS, IBD, celiac, and heartburn.
- Its German DiGA status gives prescription access through statutory insurance nationwide.
- The app combines CBT, nutrition therapy, and symptom tracking in one program.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$17.4M
Meets
Industry Average
Funded Over
3 Rounds
Benefits
Remote Work Options
Flexible Work Hours
Paid Vacation
Mental Health Support
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↓ -3%2 year growth
↓ -3%Cara Care, a Germany-based startup developing a digital platform to manage digestive health conditions such as IBS, was acquired by Mana Therapeutics, a US-based company.
SAN FRANCISCO, USA – March 12, 2024 – Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in digital digestive healthcare. This combination creates a global company offering the most comprehensive digestive health portfolio currently addressing Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Celiac Disease and Heartburn, with an exciting pipeline focused on Tinnitus, Pruritus, and Vulvodynia.
Mahana Therapeutics acquires Berlin's Cara Care, expanding digital treatment for chronic conditions.
Mahana Therapeutics acquires Cara Care to become a global leader in the digital treatment of chronic conditions.
Digestive health issues are an increasingly common struggle for people across the world. It’s something that many silently suffer and don’t receive adequate care for. Cara Care is on a mission to change this giving everyone access to digestive healthcare via their phones and they’ve just cored €6.6 million. With a commitment to holistic [] The post Berlin-based Cara Care lands €6.6 million for its digital digestive healthcare app appeared first on EU-Startups.
Cara Care is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Cara Care
Industries
Consumer Software
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Early VC
Total Funding
$17.4M
Headquarters
Berlin, Germany
Founded
2016
Cara Care is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today